Comparison of American and European Guidelines for Primary Prevention of Cardiovascular Disease
Authors:
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Systematic Coronary Risk Evaluation (SCORE)JACC, 2021
- The Global Burden of Cardiovascular Diseases and RisksJACC, 2020
- Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American IndividualsJAMA Cardiology, 2020
- Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort studyThe Lancet, 2020
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood CholesterolJACC, 2019
- 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular DiseaseJACC, 2018
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in AdultsJACC, 2018
- Disaggregation of Cause-Specific Cardiovascular Disease Mortality Among Hispanic SubgroupsJAMA Cardiology, 2017
- 2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart DiseaseJACC, 2014
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998